Evidence map›Paper›PMID 29660813›Full record

ArticleCancer2018

Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.

Usama Jazzar, Shan Yong, Zachary Klaassen, Jinhai Huo, Byron D Hughes, Edgar Esparza, Hemalkumar B Mehta, Simon P Kim, Douglas S Tyler, Stephen J Freedland and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Psychological Impact of Bladder Cancer: Insights from 219 Patients and Caregivers in Indonesia Using DASS-21 (2019-2023).Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Mental Health in Urologic Oncology.Health psychology research · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Usama JazzarDivision of Urology, The University of Texas Medical Branch at Galveston, Galveston, Texas.
Shan YongDivision of Urology, The University of Texas Medical Branch at Galveston, Galveston, Texas.
Zachary KlaassenDepartment of Surgery, Section of Urology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia.ORCID 0000-0001-7392-8916
Jinhai HuoDepartment of Health Services Research, Management and Policy, The University of Florida, Gainesville, Florida.
Byron D HughesDepartment of Surgery, The University of Texas Medical Branch at Galveston, Galveston, Texas.
Edgar EsparzaDepartment of Surgery, The University of Texas Medical Branch at Galveston, Galveston, Texas.
Hemalkumar B MehtaDepartment of Surgery, The University of Texas Medical Branch at Galveston, Galveston, Texas.ORCID 0000-0001-9134-6370
Simon P KimUrology Institute, Center for Health Care Quality and Outcomes, University Hospitals Case Western Medical Center, Case Western Reserve University, Cleveland, Ohio.ORCID 0000-0002-7117-1443
Douglas S TylerDepartment of Surgery, The University of Texas Medical Branch at Galveston, Galveston, Texas.
Stephen J FreedlandDepartment of Urology, Cedars Sinai Medical Center, Los Angeles, California.
Ashish M KamatDepartment of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Dwight V WolfDepartment of Psychiatry, The University of Texas Medical Branch at Galveston, Galveston, Texas.
Stephen B WilliamsDivision of Urology, The University of Texas Medical Branch at Galveston, Galveston, Texas.ORCID 0000-0002-2683-2185
The University of Texas Medical Branch at Galveston · USAugusta University · USCedars-Sinai Medical Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of Florida Health · USYale University · US

Funding

Targeting Ral GTPases in Bladder CancerP50CA091846 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DINNEY, COLIN P.N., MCCONKEY, DAVID J. · 2001 to 2018
$37.4M
UTMB Clinical and Translational Science AwardKL2TR001441 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI AMEREDES, BILL T · 2015 to 2024
$4.0M
SURGICAL TRAINING IN GASTROINTESTINAL ENDOCRINOLOGYT32DK007639 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI RADHAKRISHNAN, RAVI S. · 1992 to 2022
$3.6M
NCATS NIH HHS KL2 TR001441NCI NIH HHS P50 CA091846NIDDK NIH HHS T32 DK007639
6 · The paper itself

Abstract

backgroundTreatments for muscle-invasive bladder cancer are multimodal, complex, and often carry significant risks of physical and psychological morbidity. The objectives of this study were to define the incidence and types of psychiatric illnesses diagnosed after treatment and to determine their impact on survival outcomes.

methodsIn total, 3709 patients who were diagnosed with clinical stage T2 through T4a bladder cancer from January 1, 2002, to December 31, 2011, from the Surveillance, Epidemiology, and End Results-Medicare were analyzed. Multivariable analysis and Cox proportional-hazards models were used to determine the predictors associated with psychiatric diagnosis and impact on survival outcomes.

resultsOf 3709 patients, 1870 (50.4%) were diagnosed with posttreatment psychiatric disorders. Patients who underwent radical cystectomy were identified as being at significantly greater risk of having a posttreatment psychiatric illness compared with those who received radiotherapy and/or chemotherapy (hazard ratio [HR], 1.19; 95% confidence interval [CI], 1.07-1.31; P = .001). In adjusted analyses, diagnosis of a psychiatric disorder resulted in significantly worse overall survival (HR, 2.80; 95% CI, 2.47-3.17; P < .001) and cancer-specific survival (HR, 2.39; 95% CI, 2.05-2.78; P < .001).

conclusionsOne-half of patients with muscle-invasive bladder cancer who underwent treatment were diagnosed with a psychiatric disorder, which resulted in worse survival outcomes compared with patients who did not have a posttreatment psychiatric diagnosis. This information can be used to inform interventions to educate patients with muscle-invasive bladder cancer regarding the impact of different treatments on mental health. Cancer 2018. © 2018 American Cancer Society.

Indexed as

Mental DisordersAgedAge FactorsFemaleHumansMaleMedicareProportional Hazards ModelsSEER ProgramUnited StatesUrinary Bladder Neoplasmsand End Results (SEER)bladder cancerdepressionEpidemiologymortalitypsychiatricSurveillancesurvival

Identifiers

PMID29660813
PMCPMC6097900
OpenAlexW2800705226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.